Morgan Stanley Nano Vibronix, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	BUY	$0.55 - $1.19 $106 - $229	193 Added 2757.14%	200 $0
Q2 2022 Aug 15, 2022	BUY	$0.55 - $1.19 $106 - $229	193 Added 2757.14%	200 $0
Q1 2022 Oct 27, 2022	SELL	$0.7 - $1.16 $135 - $223	-193 Reduced 96.5%	7 $0
Q1 2022 May 13, 2022	SELL	$0.7 - $1.16 $77,106 - $127,776	-110,152 Reduced 99.99%	7 $0
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.0 $90,583 - $181,166	90,583 Added 462.72%	110,159 $115,000
Q3 2021 Nov 15, 2021	BUY	$0.7 - $3.37 $13,703 - $65,971	19,576 New	19,576 $40,000

Ticker NAOV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,997,800
Market Cap $16.2M
Description
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.